The World Health Organization (WHO) announced today the approval of the MVA-BN vaccine, developed by Bavarian Nordic A/S, as the first-ever mpox vaccine to be added to its prequalification list, reported Xinhua.

This prequalification approval is expected to greatly improve access to the vaccine in regions facing urgent outbreaks, especially in Africa, aiding efforts to reduce transmission and control the spread of the disease...